Contineum Therapeutics, Inc. (CTNM)
NASDAQ · Healthcare
Contineum Therapeutics, Inc. Cash Flow 2023–2024
| Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|
| Operating Activities | |||
| Operating Cash Flow | -55.3M | -32.8M | 19.3M |
| Depreciation & Amort. | 323,000 | 258,000 | 195,000 |
| Investing Activities | |||
| Capital Expenditure | 231,000 | 514,000 | 414,000 |
| Free Cash Flow | -55.5M | -33.4M | 18.9M |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Buybacks | — | — | — |
Contineum Therapeutics, Inc. Cash Flow — FAQ
Contineum Therapeutics, Inc. (CTNM) cash flow over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CTNM's cash flow history?
The chart and table above show Contineum Therapeutics, Inc.'s cash flow by year and by quarter, including the growth rate.